Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.1 SEK | +9.72% | +19.73% | +18.51% |
Sales 2021 | 844K 77.59K | Sales 2022 | 1.14M 105K | Capitalization | 595M 54.72M |
---|---|---|---|---|---|
Net income 2021 | -156M -14.34M | Net income 2022 | -168M -15.44M | EV / Sales 2021 | 1,710 x |
Net cash position 2021 | 254M 23.36M | Net cash position 2022 | 68.47M 6.29M | EV / Sales 2022 | 460 x |
P/E ratio 2021 |
-10.9
x | P/E ratio 2022 |
-3.54
x | Employees | 11 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.34% |
Latest transcript on Immunovia AB
1 day | +9.72% | ||
1 week | +19.73% | ||
Current month | +53.51% | ||
1 month | +57.89% | ||
3 months | +28.21% | ||
6 months | +269.07% | ||
Current year | +18.51% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Borcherding
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | 62 | 22-03-31 | |
Karl Stone
COO | Chief Operating Officer | 61 | 23-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 16-12-08 | |
Peter Andersen
CHM | Chairman | 67 | 19-12-31 |
Michael Löfman
BRD | Director/Board Member | - | 23-05-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 2.1 | +9.72% | 1,041,782 |
24-04-23 | 1.914 | -7.31% | 1,067,817 |
24-04-22 | 2.065 | +17.73% | 3,201,853 |
24-04-19 | 1.754 | -1.90% | 233,227 |
24-04-18 | 1.788 | +1.94% | 109,354 |
Delayed Quote Nasdaq Stockholm, April 24, 2024 at 11:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+18.51% | 8.01M | |
-12.06% | 19.32B | |
-44.61% | 2.7B | |
+16.10% | 1.83B | |
-3.24% | 1.63B | |
+20.19% | 1.2B | |
-21.52% | 896M | |
-8.03% | 726M | |
-16.68% | 701M | |
+13.21% | 527M |
- Stock Market
- Equities
- IMMNOV Stock